Delek is a downstream energy company built around petroleum refining and logistics, with additional exposure to asphalt and renewable fuels; its current story is more about managing and repositioning that asset base than launching a new operating platform. This filing formalizes an already-announced financing rather than changing the operating story. The company is documenting $400 million of 0% convertible senior notes due 2031, with authority for up to another $60 million if the over-allotment is exercised. The offering and capped calls had already been priced and were expected to close on September 29, 2026, so the filing is confirmation—not a fresh financing surprise.
| Term | Filing detail |
|---|---|
| Convertible notes | $400 million, with up to $60 million additional capacity |
| Coupon / maturity | 0% / 2031 |
| Initial conversion rate | 11.7219 shares per $1,000 note |
| Strike price | $85.3104 per share |
| Capped-call price | $117.0925 per share |
| Free convertibility date | August 1, 2031 |
| Capped-call expiration | November 1, 2031 |
The structure is designed to reduce, not eliminate, future dilution. The capped calls cover the conversion economics between the $85.3104 strike and the $117.0925 cap, and default to net-share settlement; above the cap, the hedge no longer offsets additional equity value. 〔0〕 The notes therefore give Delek five years of interest-free capital, but leave shareholders exposed to dilution if the stock ultimately rises materially beyond the cap.
The filing is weaker as a disclosure document than the headline financing suggests. The confirmation is a largely unfinalized template: the dealer, trade date, number of options, applicable percentage, premium and several ownership thresholds remain represented by placeholders. That prevents investors from determining how completely the capped calls cover the notes or what Delek paid for the hedge. The strike, cap and conversion rate are concrete, but the most important measure of dilution protection—the actual option count—is not.
For the business, this is balance-sheet funding, not a new growth commitment. The broader transaction was announced as a way to fund capped calls and use remaining proceeds for corporate purposes, including partial repayment of term-loan borrowings. The 8-K exhibit itself does not confirm the amount of debt repaid or provide a revised leverage figure, so the immediate read is limited to financing mechanics rather than proof of deleveraging.
Bottom line: Delek has locked in low-cost capital with a standard dilution-management hedge, but the filing adds little beyond a deal the market already knew was closing. Its real incremental value is limited until the final option coverage, premium and debt-paydown details are disclosed.
Read the original 8-K on SEC EDGAR ↗